The effectiveness of glucocorticoid treatment in post-COVID-19 pulmonary involvement
Abstract Rationale Persistent respiratory symptoms following Coronavirus Disease 2019 (COVID-19) are associated with residual radiological changes in lung parenchyma, with a risk of development into lung fibrosis, and with impaired pulmonary function. Previous studies hinted at the possible efficacy...
Guardat en:
| Autors principals: | , , , , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BMC
2024-02-01
|
| Col·lecció: | Pneumonia |
| Matèries: | |
| Accés en línia: | https://doi.org/10.1186/s41479-023-00123-7 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|
